Table 2

Standardised incidence ratios (SIRS) and 95% confidence intervals (CI) for pancreatic cancer among patients who had a cholecystectomy for cholelithiasis, by duration of follow up, age at entry, and calendar year at entry

TotalWith diabetes/chronic pancreatitis2-150Without diabetes/chronic pancreatitis
Obs2-151SIR95% CIObs2-151SIR95% CIObs2-151SIR95% CI
Duration of follow up (y)
 <12314.724.13–5.3702314.954.33–5.63
 1921.911.54–2.3493.841.76–7.29831.811.44–2.25
 2–327301.060.98–1.14721.851.44–2.326581.010.94–1.09
  2–41511.100.93–1.29111.580.79–2.821401.070.90–1.27
  5–92101.060.93–1.22211.961.21–2.991891.010.87–1.17
  10–141651.070.91–1.25121.340.69–2.341531.050.89–1.23
  15–191151.050.87–1.26121.830.94–3.191031.000.82–1.21
  20–32890.980.79–1.20162.781.59–4.51730.860.67–1.08
 p value for trend2-152 0.440.240.19
Calendar year at entry2-153
 1965–743521.100.99–1.22392.361.68–3.233131.030.92–1.15
 1975–842660.980.86–1.10251.530.99–2.252410.940.83–1.07
 1985–971121.160.96–1.4081.310.56–2.581041.150.94–1.40
 p value for trend0.910.050.67
Age at entry (y)2-153
 <40481.330.98–1.7777.362.96–15.2411.170.84–1.59
 40–49951.070.86–1.3092.761.26–5.24861.000.80–1.24
 50–591971.020.88–1.17181.921.14–3.041790.980.84–1.13
 60–692471.070.94–1.21201.380.84–2.122271.050.92–1.19
 ⩾701431.020.86–1.20181.650.98–2.611250.960.80–1.15
 p value for trend0.31<0.010.60
Diabetes2-153
 No6641.020.94–1.10
 Yes661.791.39–2.28
Chronic pancreatitis2-153
 No7221.040.97–1.12
 Yes83.171.37–6.24
  • 2-150 Person time before the onset of comorbidities was attributed to the comorbidity negative strata.

  • 2-151 Observed number of pancreatic cancer cases.

  • 2-152 The category of 2–4 years after index surgery was taken as the reference.

  • 2-153 The first two years of observation were not included in the analyses.